Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1487-1496

  Jelassi, Bilel ^a   Anchelin, Monique ^b   Chamouton, Julie ^a   Cayuela, María Luisa ^b   Clarysse, Lucie ^a   Li, Junyin ^c   Goré, Jacques ^a   Jiang, Lin Hua ^a,d   Roger, Sébastien ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c NANKAI UNIVERSITY   (China)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EMODIN; PURINERGIC P2X7 RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CANCER CELL; CANCER CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EMBRYO; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MICROMETASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR INVASION; ZEBRA FISH;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CALCIUM; CALCIUM SIGNALING; CELL SHAPE; CELL SURVIVAL; EMODIN; EXTRACELLULAR MATRIX; FEMALE; HEK293 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, ANIMAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; RHEUM; RNA, SMALL INTERFERING; TRANSFECTION; ZEBRAFISH;

EID: 84880265647     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt099     Document Type: Article

References (47)

1. Parkin, D.M. et al. (2005) Global cancer statistics, 2002. CA. Cancer J. Clin., 55, 74-108.
2. Gupta, G.P. et al. (2006) Cancer metastasis: building a framework. Cell, 127, 679-695.
3. Burnstock, G. (2006) Purinergic signalling. Br. J. Pharmacol., 147 (suppl. 1), S172-S181.
4. Pellegatti, P. et al. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE, 3, e2599.
5. Raffaghello, L. et al. (2006) The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res., 66, 907-914.
6. Wang, x. et al. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med., 10, 821-827.
7. White, N. et al. (2006) P2 receptors and cancer. Trends Pharmacol. Sci., 27, 211-217.
8. Roger, S. et al. (2011) P2X7 receptor antagonism in the treatment of cancers. Expert Opin. Investig. Drugs, 20, 875-880.
9. Rassendren, F. et al. (1997) The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J. Biol. Chem., 272, 5482-5486.
10. North, R.A. (2002) Molecular physiology of P2x receptors. Physiol. Rev., 82, 1013-1067.
11. Roger, S. et al. (2008) Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J. Neurosci., 28, 6393-6401.
12. Roger, S. et al. (2010) C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J. Biol. Chem., 285, 17514-17524.
13. Surprenant, A. et al. (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2x receptor (P2X7). Science, 272, 735-738.
14. Di Virgilio, F. et al. (1998) Cytolytic P2x purinoceptors. Cell Death Differ., 5, 191-199.
15. Surprenant, A. et al. (2009) Signaling at purinergic P2x receptors. Annu. Rev. Physiol., 71, 333-359.
16. Di Virgilio, F. (2007) Liaisons dangereuses: P2x(7) and the inflammasome. Trends Pharmacol. Sci., 28, 465-472.
17. Barberà-Cremades, M. et al. (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1ß release. FASEB J., 26, 2951-2962.
18. Pelegrin, P. (2008) Targeting interleukin-1 signaling in chronic inflammation: focus on P2x(7) receptor and Pannexin-1. Drug News Perspect., 21, 424-433.
19. Adinolfi, E. et al. (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood, 99, 706-708.
20. Wang, Q. et al. (2004) P2X7 receptor-mediated apoptosis of human cervical epithelial cells. Am. J. Physiol. Cell Physiol., 287, C1349-C1358.
21. Zhang, x. J. et al. (2004) Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk. Res., 28, 1313-1322.
22. Slater, M. et al. (2004) Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res. Treat., 83, 1-10.
23. Slater, M. et al. (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology, 44, 206-215.
24. Deli, T. et al. (2007) Functional genomics of calcium channels in human melanoma cells. Int. J. Cancer, 121, 55-65.
25. Solini, A. et al. (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?. Endocrinology, 149, 389-396.
26. Slater, M. et al. (2005) Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. J. Mol. Histol., 36, 159-165.
27. Di Virgilio, F. et al. (2009) P2x(7): a growth-promoting receptor-implications for cancer. Purinergic Signal., 5, 251-256.
28. Adinolfi, E. et al. (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res., 72, 2957-2969.
29. Jelassi, B. et al. (2011) P2x(7) receptor activation enhances SK3 channelsand cystein cathepsin-dependent cancer cells invasiveness. Oncogene, 30, 2108-2122.
30. Huang, H.C. et al. (1991) Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol., 198, 211-213.
31. Koyama, M. et al. (1988) Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. J. Med. Chem., 31, 283-284.
32. Tabolacci, C. et al. (2010) Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells. Life Sci., 87, 316-324.
33. Chen, Y.Y. et al. (2010) Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int. J. Oncol., 36, 1113-1120.
34. Liu, L. et al. (2010) Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor. Eur. J. Pharmacol., 640, 15-19.
35. Gillet, L. et al. (2009) Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J. Biol. Chem., 284, 8680-8691.
36. Brisson, L. et al. (2011) Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene, 30, 2070-2076.
37. Donnelly-Roberts, D.L. et al. (2007) Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol., 151, 571-579.
38. Egeblad, M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
39. Mohamed, M.M. et al. (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer, 6, 764-775.
40. Marques, I.J. et al. (2009) Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 9, 128.
41. Li, x. et al. (2006) The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol. Biomarkers Prev., 15, 1906-1913.
42. Adinolfi, E. et al. (2005) Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell, 16, 3260-3272.
43. Gu, L.Q. et al. (2010) Association of xIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma. Endocrine, 38, 276-282.
44. Ren, S. et al. (2010) Targeting P2X7 receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes. Cell Biol. Int., 34, 1205-1211.
45. Ralevic, V. et al. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
46. Böhme, H.J. et al. (1972) Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A. J. Chromatogr., 69, 209-214.
47. Baqi, Y. et al. (2010) Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions. Nat. Protoc., 5, 945-953.